HFA Premium Access

Clinical Forum - Sat. 29 April 08:30 - Tues. 02 May at 12:30

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Miscellaneous
Session type: Poster Session
Date: 29 April 2017
Time: 08:30 - 17:30

Session

9 presentations in this session

Systolic heart failure treatment with the if inhibitor ivabradine trial

Speaker: Professor M. Boehm (Homburg, DE)
Thumbnail

Real-world heart failure treatment in 10.330 patients with chronic heart failure in the netherlands

Speaker: Doctor J. Brugts (Rotterdam, NL)
Thumbnail

Clinical profiles, management and outcome of acute heart failure in Korea: results from the Korean acute heart failure registry (KorAHF)

Speaker: Associate Professor H. Lee (Seoul, KR)
Thumbnail

Non-invasive lung impedance-guided preemptive treatment in chronic heart failure patients: a randomized controlled trial (IMPEDANCE-HF Trial)

Speaker: Professor M. Kleiner Shochat (Hadera, IL)
Thumbnail

Single dose, purified biocompatible vegf a mrna administered one week post myocardial infarction in pigs inhibits cardiac fibrosis and leads to chronic reversal of global ventricular dysfunction

Speaker: Professor K. Chien (Stockholm, SE)
Thumbnail

The effect of oral iron therapy on functional capacity of heart failure patients with iron deficiency anemia

Speaker: Mrs L. Suryani (Jakarta, ID)
Thumbnail

Dapagliflozin is associated with lower risk of hospitalization for heart failure, major adverse cardiovascular events and all-cause death compared to DPP-4i in T2D patients: CVD-REAL Nordic

Speaker: Professor A. Norhammar (Stockholm, SE)
Thumbnail

Total events of hospitalization for heart failure in new users of sglt-2 inhibitors vs other glucose lowering drugs - real world data from 3 countries and more than 45,000 patients: the CVD-REA study

Speaker: Doctor M. Kosiborod (Kansas City, US)
Thumbnail

A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of 4 Weeks Treatment with Subcutaneous Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Preserved Ejection Fraction: Rationale and d

Speaker: Associate Professor H. Duengen (Berlin, DE)
Thumbnail

9 speakers from this session

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)
56 presentations
0 follower

Doctor Jasper Brugts

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
3 presentations
0 follower

Associate Professor Hae-Young Lee

Seoul National University Hospital, Seoul (Korea (Republic of))
2 presentations
0 follower

Professor Michael Kleiner Shochat

Hillel Yaffe Medical Center, Hadera (Israel)
3 presentations
0 follower

Professor Kenneth Chien

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

Mrs Lita Dwi Suryani

Fatmawati General Hospital, Jakarta (Indonesia)
1 presentation
0 follower

Professor Anna Norhammar

Karolinska Institutet, Stockholm (Sweden)
4 presentations
0 follower

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
23 presentations
0 follower

Associate Professor Hans-Dirk Duengen

Charite - Campus Virchow-Klinikum (CVK), Berlin (Germany)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk